The Half Year Results announcement shown on the Pacific Edge webpage is only one of four released to the NZ stock exchange. Full details are available at the link below for those who wish to follow up:
https://www.nzx.com/companies/PEB/announcements/258229
The third link shown on that page is the Preliminary Report. ( https://www.nzx.com/files/attachments/204637.pdf )
The second link is to a Presentation on the results, which is quite informative.( https://www.nzx.com/files/attachments/204636.pdf )
The 8th slide in the Presentation is interesting. It shows a family of four CxBladder products. CxBladder (detect) is the product currently producing revenue. CxBladder (triage) is in the process of being released to market. The CEO comments on this product in his report.
The two other products under development are for CxBladder (predict) 2015 launch, and CxBladder (monitor) intended for 2016 launch. Each should be based on the same biomarker combination that includes Midkine.
T7
Cxbladder royalty (PEB HY result), page-10
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable